Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability.
Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability.
复制标题
DOI:
10.1111/ene.12629
复制
发表时间:
2015-09
影响因子:
5.1
通讯作者:
Silberstein S
中科院分区:
文献类型:
--
作者:
Ben-Menachem E;Revesz D;Simon BJ;Silberstein S
Vagus nerve stimulation (VNS) is effective in refractory epilepsy and depression and is being investigated in heart failure, headache, gastric motility disorders and asthma. The first VNS device required surgical implantation of electrodes and a stimulator. Adverse events (AEs) are generally associated with implantation or continuous on−off stimulation. Infection is the most serious implantation‐associated AE. Bradycardia and asystole have also been described during implantation, as has vocal cord paresis, which can last up to 6 months and depends on surgical skill and experience. The most frequent stimulation‐associated AEs include voice alteration, paresthesia, cough, headache, dyspnea, pharyngitis and pain, which may require a decrease in stimulation strength or intermittent or permanent device deactivation. Newer non‐invasive VNS delivery systems do not require surgery and permit patient‐administered stimulation on demand. These non‐invasive VNS systems improve the safety and tolerability of VNS, making it more accessible and facilitating further investigations across a wider range of uses.
登录
查看更多内容
影响因子:
2.5
作者:
Foley, JO;DuBois, F
通讯作者:
DuBois, F
影响因子:
2.6
作者:
Ali, II;Pirzada, NA;Vaughn, BV
通讯作者:
Vaughn, BV
影响因子:
4.9
作者:
Goadsby, P. J.;Grosberg, B. M.;Simmons, K. A.
通讯作者:
Simmons, K. A.
影响因子:
5.6
作者:
BENMENACHEM, E;MANONESPAILLAT, R;WILLIS, J
通讯作者:
WILLIS, J
影响因子:
2.6
作者:
Ben-Menachem, Elinor;Rydenhag, Bertil;Silander, Hans
通讯作者:
Silander, Hans